| NCT03535727 |
A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer |
View |
| NCT05188573 |
EpiDetect Study: Clinical Validation of a Pancreatic Cancer Detection Test in New-Onset Diabetes Patients |
View |
| NCT03401827 |
The Effect of Gemcitabine Plus Nab-paclitaxel as Secondary Chemotherapy in Advanced Pancreatic Cancer |
View |
| NCT05500027 |
sCD8, as a Novel Biomarker for Pancreatic Cancer |
View |
| NCT00090727 |
Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma |
View |
| NCT06584227 |
Adebrelimab and Chidamide for Pancreatic Cancer |
View |
| NCT00227773 |
Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors |
View |
| NCT01900327 |
Neoadjuvant Treatment in Resectable Pancreatic Cancer |
View |
| NCT00303927 |
Capecitabine as Second-Line Therapy in Treating Patients With Stage IV Pancreatic Cancer Who Have the Thymidylate Synthase Gene |
View |
| NCT01314027 |
Adjuvant Versus Neoadjuvant Plus Adjuvant Chemotherapy in Resectable Pancreatic Cancer |
View |
| NCT04565327 |
Hyperpolarized 13C Pyruvate MRI for Treatment Response Assessment in Pancreatic Ductal Adenocarcinoma |
View |
| NCT02885727 |
Durvalumab Plus ȫooster" RT for Metastatic Adenocarcinoma Pancreas Cancer Post Chemotherapy (GCC 1598) |
View |
| NCT00034827 |
A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer |
View |
| NCT03267173 |
Evaluate the Safety and Efficacy of CAR-T in the Treatment of Pancreatic Cancer. |
View |
| NCT01529827 |
Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies |
View |
| NCT05034627 |
Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer |
View |
| NCT01291927 |
Pancreas-sparing Duodenectomy Versus Pancreatoduodenectomy for Early-stage Periampullary Carcinoma |
View |
| NCT06608927 |
Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma |
View |
| NCT04205227 |
ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors |
View |
| NCT03631173 |
Monitoring of patIents With Microdialysis Following Pancreaticoduodenectomy |
View |
| NCT03451773 |
M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma of the Pancreas |
View |
| NCT03033927 |
Predicting Effective Therapy in Pancreatic Cancer |
View |
| NCT03432676 |
Epacadostat and Pembrolizumab in Treating Participants With Advanced Pancreatic Cancer |
View |
| NCT02651727 |
Ph 1 Study of VS-4718, a FAK Inhibitor, in Combination With Nab-paclitaxel and Gemcitabine in Advanced Cancer Subjects |
View |
| NCT00001276 |
Diagnosing and Treating Low Blood Sugar Levels |
View |
